Dimpi Nitin Desai, MD
Endocrinology, Diabetes & Metabolism Physician · Palo Alto, CA
Dimpi Nitin Desai, MD is an endocrinology, diabetes & metabolism physician with a practice address in Palo Alto, California, and NPI 1780060699, issued on Aug 3, 2015. Check the license (California A179196, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Dimpi Nitin Desai
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License numbers
- A179196 CA
S3151 TX
Self-reported in NPPES; status is on the state search - Practice location
- 300 Pasteur Dr, Palo Alto, CA 94304
- Phone
- (650) 723-4000
- Enumerated
- Aug 3, 2015
- Record last updated
- Apr 28, 2024
- Medicare enrollment
- Enrolled (PECOS I20220706001063); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 300 Pasteur Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Elias Aboujaoude, MDPsychiatry Physician1649209768
- Deyaaldeen Abu Reesh, MDNeurological Surgery Physician1073201521
- Jose Acosta, MDEmergency Medicine Physician1104454446
- Connor Adams, PSYDClinical Psychologist1467081216
- Tracie Adamson, NPNurse Practitioner1982765145
- Aderinsola Aderonmu, MSStudent in an Organized Health Care Education/Training Program1083301196
Verify Dimpi Nitin Desai in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license A179196Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
63% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
983 Medicare Part D claims for 138 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 52% of claims.
Most prescribed
- Ozempic94 claims
- Levothyroxine Sodium92 claims
- Mounjaro72 claims
- Metformin Hcl Er68 claims
- Hydrocortisone54 claims
- Glipizide49 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 76.5 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $121.43
1 payment: food and beverage; the largest payer was Abbott Laboratories. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
One hospital affiliation
- Stanford Health CareStanford, CA · Acute Care Hospitals5 of 5 stars
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.
Endocrinology, Diabetes & Metabolism Physician providers in California
There are 1,131 endocrinology, diabetes & metabolism physician records in California.
Other endocrinology, diabetes & metabolism physician records in California
- Evan Abel, MDSanta Monica, CA1619067238
- Anita Abraham, M.D.Stockton, CA1558380337
- Sallie Adams, M.D.Roseville, CA1255342085
- Helen Adelberg, M.D.Encino, CA1093935447
- Yewande Adepoju, DOOroville, CA1467892984
- David Aftergood, MDBeverly Hills, CA1639259328
- Nidhi Agarwal, MDTorrance, CA1518387125
- Bahar Aghighi, MDSanta Cruz, CA1770562134
- Tyler Aguinaldo, MDBurlingame, CA1306811906
- Susan Ahern, D.O.Ventura, CA1508156597
Common questions
What is Dimpi Nitin Desai, MD's NPI number?
Dimpi Nitin Desai, MD's National Provider Identifier (NPI) is 1780060699, issued on Aug 3, 2015. An NPI identifies a provider in billing; it is not a license.
Where is Dimpi Nitin Desai, MD located?
The NPPES record lists a practice address at 300 Pasteur Dr, Palo Alto, CA, 94304. Phone: (650) 723-4000. Providers update this record themselves, so call before visiting.
How can I verify Dimpi Nitin Desai, MD's license?
NPPES lists California license number A179196, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Dimpi Nitin Desai, MD prescribe under Medicare Part D?
In 2024, Dimpi Nitin Desai, MD had 983 Medicare Part D claims for 138 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
What is Dimpi Nitin Desai, MD's MIPS final score?
The 2023 MIPS final score is 76.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.